Molinari E, Gilman M, Natesan S
ARIAD Gene Therapeutics Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
EMBO J. 1999 Nov 15;18(22):6439-47. doi: 10.1093/emboj/18.22.6439.
We show that the intracellular concentration of transcriptional activator proteins is regulated by the proteasome-mediated protein degradation pathway. The rate of degradation of activators by proteasomes correlates with activation domain potency in vivo. Mutations either in the activation domain residues involved in target protein interaction or in the DNA-binding domain residues essential for DNA binding abolish the transcriptional activation function in vivo and render the activator resistant to degradation by proteasomes. Finally, using a rapamycin-regulated gene expression system, we show that recruiting activation domains to DNA-bound receptor proteins greatly enhanced the rate of degradation of reconstituted activators. These observations suggest that in mammalian cells efficient recruitment of activator-target protein complexes to the promoter means that they are subjected to rapid degradation by proteasomes. We propose that proteasome-mediated control of the intracellular levels of transcriptional activators could play an important role in the regulation of gene expression.
我们发现转录激活蛋白的细胞内浓度受蛋白酶体介导的蛋白质降解途径调控。蛋白酶体对激活蛋白的降解速率与体内激活结构域的活性相关。参与靶蛋白相互作用的激活结构域残基或对DNA结合至关重要的DNA结合结构域残基发生突变,均会消除体内的转录激活功能,并使激活蛋白对蛋白酶体降解产生抗性。最后,利用雷帕霉素调控的基因表达系统,我们发现将激活结构域招募至与DNA结合的受体蛋白上,会极大提高重组激活蛋白的降解速率。这些观察结果表明,在哺乳动物细胞中,激活蛋白-靶蛋白复合物有效募集至启动子意味着它们会被蛋白酶体快速降解。我们提出,蛋白酶体介导的对转录激活蛋白细胞内水平的控制可能在基因表达调控中发挥重要作用。